tRF-18-8R1546D2 is upregulated in hepatocellular carcinoma and associated with poor prognosis and tumor progression
Liu-Xia Yuan, Zhi-Qiang Yue, Jing-Wen Xiao, Lin-ling Ju, Hui-Xuan Wang, Jia-Jia Tan, Feng Xiao, Lin Chen · 2026
Read tRF-18-8R1546D2 is upregulated in hepatocellular carcinoma and associated with poor prognosis and tumor progression by Liu-Xia Yuan, Zhi-Qiang Yue, Jing-Wen Xiao, Lin-ling Ju, Hui-Xuan Wang, Jia-Jia Tan, Feng Xiao, Lin Chen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13364791.txt.
Description
Liu-Xia Yuan and co-workers study in 2026 a tiny RNA bit that runs high in liver cancer and may drive its growth. The bit, found by a gene chip scan, sat high in tumor flesh, cell lines, and blood. High ranks track with poor life odds and may aid early spotting.
Cell tests show the bit speeds growth, move, and spread, and cuts cell death. Its knock down flips each trait. The bit seems to mute a guard gene that slows spread paths. The team casts the bit as a mark and aim for liver cancer care.
Catalog record
| CREATOR | Liu-Xia Yuan, Zhi-Qiang Yue, Jing-Wen Xiao, Lin-ling Ju, Hui-Xuan Wang, Jia-Jia Tan, Feng Xiao, Lin Chen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31256 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |